{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:51:57Z","timestamp":1791571917213,"version":"4.3.4"},"reference-count":9,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018996","name":"Hellenic Academic Libraries Link","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005187","name":"National and Kapodistrian University of Athens","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005187","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.numecd.2026.104823","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T04:32:56Z","timestamp":1780720376000},"page":"104823","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of lipid-lowering treatment on the performance of SCORE2 algorithms in detecting high-risk individuals"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2098-1665","authenticated-orcid":false,"given":"Anastasios","family":"Kollias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos G.","family":"Kyriakoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikaterini","family":"Komnianou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Tsaganos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitra","family":"Krystallaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariadni","family":"Menti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eirini-Chrysovalanti","family":"Antonogiannaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George S.","family":"Stergiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"42","key":"10.1016\/j.numecd.2026.104823_bib1","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1093\/eurheartj\/ehaf190","article-title":"2025 focused update of the 2019 ESC\/EAS guidelines for the management of dyslipidaemias","volume":"46","author":"Mach","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2026.104823_bib2","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.125.047764","article-title":"Routine handheld carotid ultrasonography for cardiovascular risk stratification and primary prevention treatment decisions in a contemporary middle-aged general population","author":"Kollias","year":"2026","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.numecd.2026.104823_bib3","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.atherosclerosis.2017.08.014","article-title":"Effects of age, gender and statin dose on lipid levels: results from the VOYAGER meta-analysis database","volume":"265","author":"Karlson","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.numecd.2026.104823_bib4","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.3390\/jcm14072220","article-title":"Cardiovascular risk assessment and lipid-lowering therapy recommendations in primary prevention","volume":"14","author":"Komnianou","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.numecd.2026.104823_bib5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/eurjpc\/zwab154","article-title":"2021 ESC guidelines on cardiovascular disease prevention in clinical practice","volume":"29","author":"Visseren","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.numecd.2026.104823_bib6","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.030739","article-title":"Carotid plaque score for stroke and cardiovascular risk prediction in a middle-aged cohort from the general population","volume":"12","author":"Ihle-Hansen","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.numecd.2026.104823_bib7","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/eurjpc\/zwad352","article-title":"Validation of the European SCORE2 models in a Canadian primary care cohort","volume":"31","author":"Sud","year":"2024","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.numecd.2026.104823_bib8","doi-asserted-by":"crossref","DOI":"10.1093\/eurjpc\/zwaf253","article-title":"Underestimation of cardiovascular risk by the SCORE2 model in primary care: a call for recalibration","author":"Voorbrood","year":"2025","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.numecd.2026.104823_bib9","doi-asserted-by":"crossref","DOI":"10.1093\/eurjpc\/zwaf555","article-title":"SCORE2 charts assign a different risk category than the underlying model in a large portion of Polish primary care patients","author":"Go\u0142awski","year":"2025","journal-title":"Eur J Prev Cardiol"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475326002851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475326002851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:07:56Z","timestamp":1791569276000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475326002851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":9,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0939475326002851"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2026.104823","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of lipid-lowering treatment on the performance of SCORE2 algorithms in detecting high-risk individuals","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2026.104823","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University.","name":"copyright","label":"Copyright"}],"article-number":"104823"}}